Top Biotech Companies Are Making Steady Progress In Developing Treatments To Fight Alzheimer’s Disease
December 21, 2022 at 20:40 PM EST
The estimated cost of Alzheimer's disease and related dementia care in 2021 was $355B. Investing in the top companies that are progressing toward a treatment for Alzheimer’s can bring handsome investment returns.
